Lumida
/RCEL
⌘K
AVITA Medical Inc

AVITA Medical Inc

RCEL
$9.88USD+0.20%+0.02 today

MARKET CAP

305.6M

P/E (TTM)

FWD P/E

DAY RANGE

$10 – $10

52W RANGE

$3
$11

AI Summary

Stalk
TrimMedium

RCEL remains in a sustained Stage 4 decline with persistent lower highs and lower lows and price below all key moving averages. Oversold conditions at current levels increase the risk of a bounce, so under the speculative strategy we defer selling to rallies into resistance around the EMAs to ensure asymmetric entry.

  • Q2 revenue of $21.7M grew 18% YoY driven by RECELL sales.
  • Full-year 2026 revenue guidance boosted to $86–89M with Q4 cash-flow breakeven forecast.
  • Negative earnings yield and weak book-to-price suggest rich valuation.
Full analysis →
Insider Trades23 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 12, 2026BuyRCELDavid D O'TooleCFO2,000$3.97$305.6M-13.26%+206.83%$7.9K+1.33%Trim
May 29, 2026BuyRCELCary Guy VancePresident and CEO5,000$3.05$305.6M-13.26%+206.83%$15.3K+13.98%Trim
May 29, 2026BuyRCELDavid D O'TooleCFO5,000$3.05$305.6M-13.26%+206.83%$15.3K+3.43%Trim
May 20, 2026BuyRCELDavid D O'TooleCFO2,000$4.26$305.6M-13.26%+206.83%$8.5K+1.39%Trim
May 19, 2026BuyRCELDavid D O'TooleCFO2,000$4.24$305.6M-13.26%+206.83%$8.5K+1.41%Trim
Mar 11, 2026BuyRCELDavid D O'TooleCFO1,800$4.78$305.6M-13.26%+206.83%$8.6K+1.28%Trim
Feb 19, 2026BuyRCELDavid D O'TooleCFO3,000$4.15$305.6M-13.26%+206.83%$12.5K+2.19%Trim
Aug 26, 2025BuyRCELDavid D O'TooleCFO2,000$4.52$305.6M-13.26%+206.83%$9.0K+6.74%Trim
Aug 12, 2025BuyRCELDavid D O'TooleCFO2,000$4.81$305.6M-13.26%+206.83%$9.6K+7.23%Trim
May 30, 2025BuyRCELDavid D O'TooleCFO1,923$4.78$305.6M-13.26%+206.83%$9.2K+7.47%Trim
Feb 20, 2025BuyRCELDavid D O'TooleCFO1,000$9.90$305.6M-13.26%+206.83%$9.9K+4.04%Trim
Feb 19, 2025BuyRCELDavid D O'TooleCFO1,000$10.25$305.6M-13.26%+206.83%$10.3K+4.21%Trim
Nov 29, 2024BuyRCELDavid D O'TooleCFO1,760$10.40$305.6M-13.26%+206.83%$18.3K+2.59%Trim
May 31, 2024BuyRCELDonna ShiromaGeneral Counsel2,225$8.17$305.6M-13.26%+206.83%$18.2K+5.09%Trim
May 30, 2024BuyRCELDavid D O'TooleCFO3,240$8.39$305.6M-13.26%+206.83%$27.2K+5.62%Trim
Feb 28, 2024BuyRCELDavid D O'TooleCFO1,250$17.39$305.6M-13.26%+206.83%$21.7K+3.48%Trim
Dec 26, 2023SellRCELJames CorbettCEO1,445$13.29$305.6M-13.26%+206.83%$19.2K-11.09%Trim
Dec 12, 2023BuyRCELDavid D O'TooleCFO950$12.45$305.6M-13.26%+206.83%$11.8K+5.75%Trim
Nov 30, 2023BuyRCELDonna ShiromaGeneral Counsel1,469$9.06$305.6M-13.26%+206.83%$13.3K+1.03%Trim
Nov 30, 2023BuyRCELDavid D O'TooleCFO1,534$9.59$305.6M-13.26%+206.83%$14.7K+4.94%Trim
Nov 21, 2023BuyRCELDavid D O'TooleCFO2,000$10.28$305.6M-13.26%+206.83%$20.6K+7.41%Trim
Nov 16, 2023BuyRCELDavid D O'TooleCFO2,000$12.30$305.6M-13.26%+206.83%$24.6K+8.70%Trim
Nov 14, 2023BuyRCELDavid D O'TooleCFO2,000$13.06$305.6M-13.26%+206.83%$26.1K+10.53%Trim